Delfi Diagnostics

Delfi Diagnostics

Delfi Diagnostics

Delfi Diagnostics detect cancer early, when it is most curable, using high precision non-invasive blood tests.
Founded
2019
Raised
$100M
Follow us
Latest funding
$100,000,000
Venture capital (Series A) - 2021
Menlo Ventures Foresite Capital Rock Springs Capital +7
Team Size
1–10
Employees
neurons.AI

Best in Tech Awards 2021: Delfi Diagnostics

$100,000,000 Venture capital (Series A)
neurons.AI

Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test

neurons.AI

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early …